← Back to Search

Behavioral Intervention

Cognitive Processing Therapy for PTSD

N/A
Recruiting
Led By Michael Koenigs, PhD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
no current psychosis symptoms
18 years of age or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study duration (up to 2 years)
Awards & highlights

Study Summary

This trial will explore if a therapy group led by people with prison experience can help reduce symptoms of PTSD for those directly impacted by incarceration.

Who is the study for?
This trial is for adults over 18 who have been in prison or jail and are now dealing with PTSD. They must need treatment for PTSD, not be currently experiencing psychosis or actively harming themselves or feeling suicidal, and be willing to join group therapy.Check my eligibility
What is being tested?
The study tests Cognitive Processing Therapy in a group setting led by peers with similar incarceration experiences. It aims to see if this approach can reduce PTSD symptoms after a 6-week program among those affected by time spent in correctional facilities.See study design
What are the potential side effects?
While the trial focuses on therapy rather than medication, participants may experience emotional discomfort as they process traumatic events during sessions. This could include increased anxiety, memories of past trauma, or changes in mood.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am not experiencing symptoms of psychosis.
Select...
I am 18 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study duration (up to 2 years)
This trial's timeline: 3 weeks for screening, Varies for treatment, and study duration (up to 2 years) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in PTSD symptom severity
Change in suicide and self-harm ideation
Feasibility: Compliance through completing assessments
+7 more
Secondary outcome measures
Change in anxiety symptom severity
Change in aspects of hopelessness
Change in depression symptom severity
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Cognitive Processing Therapy (CPT)Experimental Treatment1 Intervention
Groups of 6-8 receive CPT to treat PTSD
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Processing Therapy
2016
N/A
~3400

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,189 Previous Clinical Trials
3,169,474 Total Patients Enrolled
Michael Koenigs, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison
2 Previous Clinical Trials
154 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this analysis currently recruiting participants?

"Per the information on clinicaltrials.gov, this research endeavour is not presently looking for test subjects. It was first posted in September of 2023 and its last update occurred on August 25th of that same year. However, there are still 325 other studies recruiting patients at present."

Answered by AI

What are the projected outcomes of this research endeavor?

"Over a period of up to two years, this trial will evaluate the compliance rate amongst participants. Secondary objectives include measuring changes in trauma-related thoughts and beliefs (using Posttraumatic Cognitions Inventory), levels of hopelessness (Beck Hopelessness Scale) and substance use (Tobacco, Alcohol, Prescription Medication and other Substance Use Tool)."

Answered by AI
~48 spots leftby Sep 2025